Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failureYoshiyuki Kusakari, Setsuya Aiba, Kenshi Yamasaki et al.|The Journal of Dermatology|2015Cited by 28
Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patientsRiichiro Sugiura, Kenshi Yamasaki, Toshiya Takahashi et al.|The Journal of Dermatology|2021Cited by 11
Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-α antagonist treatment using a novel interleukin-8 reporter cell lineYutaka Kimura, Setsuya Aiba, Ryoko Shimada‐Omori et al.|British Journal of Dermatology|2016Cited by 5
Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control studyH. Terui, Kenshi Yamasaki, Ryoko Shimada‐Omori et al.|The Journal of Dermatology|2021Cited by 4
Acquired idiopathic generalized anhidrosis after novel coronavirus (<scp>SARS‐CoV</scp>‐2) infectionYoshiko Mikami, Yoshihide Asano, Taku Fujimura et al.|The Journal of Dermatology|2023Cited by 1